Luke Strnad
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- Antimicrobial Resistance in Staphylococcus
Papers in
- Epidemiology 13
- Mycobacterium research and diagnosis 6
- Fungal Infections and Studies 3
-
- Antimicrobial Resistance in Staphylococcus 5
- Clostridium difficile and Clostridium perfringens research 3
- Tuberculosis Research and Epidemiology 3
- Co-authors
- Kevin Winthrop (6 shared papers)Monica K Sikka (10 shared papers)Honora Englander (4 shared papers)Adithya Cattamanchi (1 shared paper)Priya B. Shete (1 shared paper)Christen M. Gray (1 shared paper)Philip M. Polgreen (2 shared papers)Susan E. Beekmann (2 shared papers)
- Journals
- Open Forum Infectious Diseases (13 papers)Clinical Infectious Diseases (2 papers)Therapeutic Advances in Infectious Disease (2 papers)Infection Control and Hospital Epidemiology (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- United StatesEthiopiaSouth Africa
In The Last Decade
Luke Strnad
28 papers receiving 302 citations
Peers
Comparison fields: 5 of 55
- Applied Microbiology and Biotechnology 14
- Infectious Diseases 106
- Epidemiology 181
- Small Animals 31
- Microbiology 3
Countries citing papers authored by Luke Strnad
This map shows the geographic impact of Luke Strnad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Strnad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Strnad more than expected).
Fields of papers citing papers by Luke Strnad
This network shows the impact of papers produced by Luke Strnad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Strnad. The network helps show where Luke Strnad may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Strnad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 57 | |
| 2 | 2020 | 53 | |
| 3 | 2018 | 50 | |
| 4 | 2018 | 32 | |
| 5 | 2021 | 31 | |
| 6 | 2023 | 15 | |
| 7 | 2019 | 12 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2019 | 2 | |
| 19 | Personality of the medical student. | 1980 | 2 |
| 20 | 2022 | 2 |
About Luke Strnad
Luke Strnad is a scholar working on Epidemiology, Infectious Diseases, Applied Microbiology and Biotechnology, Surgery and Geriatrics and Gerontology, having authored 32 papers that have together received 305 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Mycobacterium research and diagnosis (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Fungal Infections and Studies (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Tuberculosis Research and Epidemiology (3 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (14 citations), Infectious Diseases (106 citations), Epidemiology (181 citations), Small Animals (31 citations) and Microbiology (3 citations). Luke Strnad has collaborated with scholars based in United States, Ethiopia and South Africa. Frequent co-authors include Kevin Winthrop, Monica K Sikka, Honora Englander, Adithya Cattamanchi, Priya B. Shete, Christen M. Gray, Philip M. Polgreen, Susan E. Beekmann, Henry F. Chambers and Catherine Liu. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, Therapeutic Advances in Infectious Disease, Infection Control and Hospital Epidemiology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.